Aziyo biologics reports first quarter 2021 financial results and increases 2021 revenue guidance

Silver spring, md., may 04, 2021 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the three months ended march 31, 2021.

AZYO Ratings Summary

AZYO Quant Ranking